ScreenerHero

HEPA Hepion Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · hepionpharma.com
0.0626USD+0.16%Mkt Cap: 5.65M $P/E: —

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It develop…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap5.65M USD
Enterprise Value10.89M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.28M USD
Revenue/Share—
Last Price0.0626 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4268971045
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-8.57
EPS (TTM)-0.23
EPS (Forward)-11.43
52W Range
0.034038% of range0.1100
52W High0.1100 USD
52W Low0.0340 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-310.32%
ROA-269.64%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.27M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-7.37%
Net Debt-1.63M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.02
Current Ratio3.91
Quick Ratio3.31
Book Value/Sh-0.01 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateJun 3, 2019
Splits
Last Split1:50
Split DateMar 18, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.98.22M
Float43.19M
Insiders66.43%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float4.10%
Short % Out.4.10%
Shares Short448.18K
Short (prev mo.)199.81K
Technical
SMA 500.0726 (-13.8%)
SMA 2000.0608 (+2.9%)
Beta1.75
S&P 52W Chg16.45%
Avg Vol (30d)19.33K
Avg Vol (10d)63.36K
Technical Indicators
RSI (14)50.5
MACD0.0009
MACD Signal0.0016
MACD Hist.-0.0006
BB Upper0.0796 USD
BB Middle0.0657 USD
BB Lower0.0518 USD
BB Width42.32%
ATR (14)0.0108 USD
Vol Ratio (20d)0.59x